宜通世紀(300310.SZ):預中標廣東鐵塔2022-2024年綜合代維項目
格隆匯3月31日丨宜通世紀(300310.SZ)公佈,公司參與了“廣東鐵塔2022-2024年綜合代維項目”的投標,近日,項目採購人中國鐵塔股份有限公司廣東省分公司和採購代理人新華招標有限公司對上述項目的中標候選人進行公示,公司為中標候選人之一。
項目總採購預算為人民幣14.348億元(含税),最終規模及詳細服務內容以實際委託訂單為準;項目中選人數量為10個,每個中選人只能中選1個份額。公司成為該項目第五中標候選人,預計折扣後中選金額為1.275億元(含税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.